Dancy M, Evans G, Gaitonde M K, Maxwell J D
Br Med J (Clin Res Ed). 1984 Jul 14;289(6437):79-82. doi: 10.1136/bmj.289.6437.79.
Thiamine state was investigated in patients with alcoholic liver disease, patients with various non-alcoholic liver diseases, and controls using a direct technique (thiochrome assay) to measure thiamine, thiamine monophospate, and the active coenzyme thiamine pyrophosphate in whole blood after isolating the fractions by ion exchange chromatography. Overall nutrition was similar in all groups as assessed by anthropometry, and no patient had clinical evidence of thiamine deficiency. There was no significant difference among the groups in mean concentration of any form of thiamine. The scatter was much greater in patients with alcoholic liver disease but only 8.7% had biochemical thiamine deficiency (defined as a blood concentration of the active coenzyme greater than 2 SD below the mean control value). An unexpected finding was of abnormally high total thiamine concentrations (greater than 2 SD above the mean control value) in 17.4% of patients with alcoholic liver disease, the highest concentrations being found in two patients with severe alcoholic hepatitis and cirrhosis. The ratio of phosphorylated to unphosphorylated thiamine was calculated as an index of phosphorylation and, although the mean did not differ significantly among the groups, the range was greatest in alcoholic liver disease. The lowest ratios occurred in the two patients with severe alcoholic hepatitis, but neither had evidence of thiamine pyrophosphate deficiency. Contrary to studies using indirect assay techniques, these results suggest that thiamine deficiency is unusual in well nourished patients with alcoholic liver disease. The new finding of unexpectedly high thiamine concentrations in some patients may be due to abnormalities of hepatic storage or release in liver disease, particularly in severe alcoholic hepatitis. There was no convincing evidence of impaired thiamine phosphorylation in any patients with liver disease. Conclusions from studies using indirect assays on the prevalence and mechanisms of thiamine deficiency in liver diseases may not be valid.
采用直接技术(硫色素法),通过离子交换色谱分离组分后,测定酒精性肝病患者、各种非酒精性肝病患者及对照组全血中的硫胺素、硫胺素单磷酸酯和活性辅酶硫胺素焦磷酸,以此来研究硫胺素状态。通过人体测量评估,所有组的总体营养状况相似,且无患者有硫胺素缺乏的临床证据。各形式硫胺素的平均浓度在组间无显著差异。酒精性肝病患者的离散度更大,但仅有8.7%的患者存在生化性硫胺素缺乏(定义为活性辅酶的血浓度比对照均值低2个标准差以上)。一个意外发现是,17.4%的酒精性肝病患者硫胺素总浓度异常高(比对照均值高2个标准差以上),最高浓度见于两名重症酒精性肝炎和肝硬化患者。计算磷酸化硫胺素与未磷酸化硫胺素的比值作为磷酸化指标,尽管各组均值无显著差异,但酒精性肝病组的范围最大。最低比值出现在两名重症酒精性肝炎患者中,但两人均无硫胺素焦磷酸缺乏的证据。与使用间接检测技术的研究相反,这些结果表明,营养良好的酒精性肝病患者中硫胺素缺乏并不常见。一些患者硫胺素浓度意外升高这一新发现,可能是由于肝病时肝脏储存或释放异常,尤其是在重症酒精性肝炎中。没有令人信服的证据表明任何肝病患者存在硫胺素磷酸化受损。基于间接检测对肝病中硫胺素缺乏的患病率和机制所做研究的结论可能无效。